Minerva Neurosciences(NERV)
$2.18+0.02 (+0.93%)
NERV
Minerva Neurosciences financials statements
$2.18
At close:+0.02 (+0.93%)
Want to see NERV full AI Analyst Report?
Minerva Neurosciences (NERV) Ratios
625 Followers
Minerva Neurosciences Ratios
NERV's free cash flow for Q3 2026 was $-8.15M. For the 2026 fiscal year, NERV's free cash flow was increased by $0.00 and operating cash flow was $-8.15M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 36.29 | 7.85 | 12.57 | 29.15 | 22.07 |
| Quick Ratio | 36.29 | 7.85 | 12.57 | 29.15 | 22.07 |
| Cash Ratio | 35.94 | 7.53 | 12.25 | 26.20 | 21.55 |
| Solvency Ratio | -1.23 | 0.02 | -0.35 | -0.43 | -0.72 |
| Operating Cash Flow Ratio | -5.90 | -6.89 | -4.43 | -17.89 | -8.73 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -155.62M | $ -40.57M | $ -43.35M | $ -34.95M | $ -6.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | -0.46 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | -0.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | -0.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.70 | -1.45 | -2.00 | -2.75 | 9.67 |
| Debt Service Coverage Ratio | 0.00 | 1.32 | -2.62 | -3.33 | -6.87 |
| Interest Coverage Ratio | 0.00 | -4.79 | -2.79 | -3.41 | -7.17 |
| Debt to Market Cap | 1.91 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 7.68 | 0.60 | 1.27 | 1.39 | 1.18 |
| Net Debt to EBITDA | 0.06 | -3.55 | 1.89 | 1.46 | 1.34 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 96.51% |
| EBT Per EBIT | 1942.82% | -6.59% | 129.78% | 127.26% | 113.98% |
| Return on Assets (ROA) | -299.51% | 3.87% | -52.73% | -58.29% | -64.71% |
| Return on Equity (ROE) | 208.47% | -5.60% | 105.44% | 160.35% | -625.73% |
| Return on Capital Employed (ROCE) | -15.79% | -63.69% | -43.17% | -46.98% | -61.05% |
| Return on Invested Capital (ROIC) | -15.79% | -63.69% | -43.17% | -46.98% | -58.93% |
| Return on Tangible Assets | -353.10% | 6.46% | -71.42% | -79.92% | -80.23% |
| Earnings Yield | -862.37% | 8.56% | -74.99% | -378.17% | -145.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.60 | -2.58 | -2.27 | -4.62 | -4.61 |
| Free Cash Flow Per Share | -1.60 | -2.58 | -2.27 | -4.62 | -4.61 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | -1509.56 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -1509.56 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -39.71% | -116.35% | -36.95% | -290.46% | -71.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.12 | 11.68 | -1.33 | -0.26 | -0.69 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.24 | -0.65 | -1.41 | -0.42 | 4.29 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.52 | -0.86 | -2.71 | -0.34 | -1.39 |
| Price-to-Operating Cash Flow Ratio | -2.52 | -0.86 | -2.71 | -0.34 | -1.39 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.11 | 0.06 | 0.01 | 0.00 |
| Enterprise Value Multiple | -0.06 | -0.76 | 0.04 | 1.12 | 0.59 |
| Enterprise Value | 16.69M | -4.56M | -900.67K | -27.60M | -26.53M |
| EV to EBITDA | -0.06 | -0.76 | 0.04 | 1.12 | 0.59 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -1.23 | 0.23 | 0.06 | 1.12 | 1.08 |
| EV to Operating Cash Flow | -1.23 | 0.23 | 0.06 | 1.12 | 1.08 |
| Tangible Book Value Per Share | -18.39 | -5.36 | -6.66 | -6.54 | -1.30 |
| Shareholders’ Equity Per Share | -16.63 | -3.39 | -4.37 | -3.75 | 1.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -34.67 | 0.19 | -4.61 | -6.01 | -9.35 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.97 |
| Interest Burden | 1.00 | 0.24 | 1.38 | 1.30 | 1.14 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.05 | -13.59 | 0.49 | 0.77 | 0.49 |
Currency in USD

